"I have seen 400 contracts for everything: vaccines, monoclonal antibodies, the masks, even swabs tests, staffing, logistics and everything related to COVID-19," she told host Maria Zeee during the recent episode of "Maria Zeee Uncensored."
The researcher said the DoD and the Biomedical Advanced Research and Development Authority (BARDA) give different grants and contracts for the development of these kinds of things. "So these contracts are all with DoD and BARDA as well as the Department of Health and Human Services (HHS). They actually merge into the same organization and report to the executive branch of the government.
She also pointed out that the defense department launched "Operation Warp Speed," which was explicitly the "chief operating officer" of the whole organization. "There's a layer of U.S. government that designs, develops, manufactures and tests these products (vaccines), but is under the oversight of the DoD. But the legal structure is that when then HHS Secretary Alex Azar decides whether they are effective, they can be released on the market," she said. "Under the Trump administration, Azar was that person who pulled that trigger."
Latypova, who heads the investigative group Team Enigma, noted that the emergency use authorization (EUA) adopted in 1997 and amended in 2003, 2004, 2005, 2013 and 2017, enables the HHS secretary to use EUA-covered medical countermeasures, which doesn't constitute a clinical investigation of trials.
Meaning, the official public health regulator Food and Drug Administration (FDA) does not actually play a role in the drug trials. "FDA has been acting and playing a theater and pretending to be a regulator. And that's the fraud that has been committed on all of us," the Enigma team leader said.
The team also uncovered how substandard and unsanitary the vaccine factories are. Latypova cited the existence of a redacted FDA Audit Form 483 that indicated deviations from the standard operating procedures, which her team obtained via a Freedom of Information Act request.
The form noted that one vaccine factory is not maintained and not of suitable size, design and location to facilitate cleaning, maintenance and proper operation. Moreover, the auditors wrote that procedures to prevent cross-contamination were not executed in the facility's manufacturing protocol. (Related: Live with Dr. Jane Ruby: Sasha Latypova exposes unsanitary COVID-19 vaccine manufacturing facility.)
Brook Jackson was working as the director of operations for a multi-state site management organization and was in charge of supervising the testing of SARS-CoV-2, as well as Abbott's RT-PCR technologies and the early phase trials of remdesivir at the start of the pandemic.
In September 2020, she became the Ventavia Research Group regional director. Her task was to oversee the conduct of Pfizer's Phase 3 Covid-19 mRNA "vaccine" trial at several locations in Texas.
"In the 20 years that I have been involved in clinical research, I have never seen a study conducted by an investigative site, managed by a contractor or overseen by a pharmaceutical sponsor that scared me, until then. What I documented and reported to my former employer and to Pfizer during an internal audit was dangerous and violated federal law. I felt that I had a responsibility to make sure that the participants were protected and the fraudulent data being collected in the study was not used in any safety and efficacy analysis," Jackson said on her website.
Within hours after reporting the irregularities to the FDA, Jackson was fired. She has since sued Pfizer.
"Jackson was under the impression she was participating in a clinical trial and was supposed to monitor it and report to FDA when the violations happened. In reality, she was participating in the theatrical performance," Latypova said.
She also pointed out how legislation that goes back to President Abrahan Lincoln – during the war times when the government was being sold defective products – can be a basis for Jackson's case. The said law was designed to protect the government from false claims.
"Recently, Pfizer filed a motion to dismiss, citing one of the contracts with the DoD and their premise was that they're not making false claims, Latypova said. In the motion to dismiss, Pfizer said: "Under this contract our scope of work is a demonstration of large-scale manufacturing."
Zeee lamented that the DoD may have already told Big Pharma how to get away with this as well.
Check out BigPharmaNews.com for more stories related to Pfizer's fake clinical trials.
Watch the full episode of "Maria Zeee Uncensored" featuring Sasha Latypova below.
This video is from the Deception is Not True Consent channel on Brighteon.com.